Atripla approved in Europe

January 3, 2008
Sales and Marketing HIV

The first ever product to combine all the drugs HIV patients need in just one daily pill has been approved …

The Pharmafocus Interview: John Patterson

December 19, 2007
Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations

John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …

Delayed Galvus cleared for 2008 European launch

December 19, 2007
Sales and Marketing EU, diabetes

A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …

Cervarix US approval delayed

December 19, 2007
Research and Development, Sales and Marketing

GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …

Novartis to make new round of job cuts

December 19, 2007
Sales and Marketing

Novartis will cut around 2,500 jobs as part of a new streamlining programme that aims to save $1.6 billion by …

Northbank joins communications consultancy College Hill

December 19, 2007
Medical Communications

Northbank Communications has been acquired by College Hill, in a deal that will extend its international reach and add new …

Latest news from Datamonitor

December 18, 2007
Research and Development

BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …

NICE and Novartis work on groundbreaking pilot

December 18, 2007
Sales and Marketing

NICE could provide early advice to pharma companies on the data it requires for its appraisals, if a new pilot …

Providing training to the NHS: a learning curve for pharma too

December 18, 2007
Sales and Marketing NHS, pharma, training

It hardly needs to be said that each wave of NHS reorganisation has brought new challenges in terms of pharma …

Eisai signs $3.9bn biotech deal

December 14, 2007
Research and Development, Sales and Marketing Eisai

Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …

Costly private practices will not improve service, warns BMA

December 14, 2007

The government's pledge to build 100 new practices in under-doctored areas could make health inequalities in Britain even worse, according …

Bayer Schering blood clotting drug a ‘major leap forward’

December 14, 2007
Sales and Marketing Bayer, Xarelto, clot

Bayer Schering says its new blood clotting drug Xarelto is poised to set a new standard of care for post-surgery …

GSK boosts portfolio in cancer and anti-infectives

December 14, 2007
Research and Development

GSK has secured two new early-stage biotech licensing deals to boost its product pipeline.The UK-based group unveiled one partnership with …

NICE bends to pressure over Lucentis

December 14, 2007
Sales and Marketing AMD, Lucentis, NICE

NICE is set to change its guidance for blindness treatment Lucentis following a barrage of complaints over its failure to …

Get ready for inspection

December 13, 2007
Research and Development MHRA, inspection, reg affairs

No one looks forward to receiving a letter from the MHRA (Medicines and Healthcare products Regulatory Agency) inspectorate announcing their …

Herefordshire pioneers PCT and council merger

December 12, 2007
Sales and Marketing

A revolutionary new 'public service trust' has been created in Herefordshire, and will be the first to integrate a PCT …

Supply chain could inflate prices, says watchdog

December 12, 2007
Sales and Marketing

The NHS could face steeper prices on drugs due to manufacturers adopting a new restrictive distribution model, according to a …

Stout to quit as GSK restructures

December 10, 2007
Sales and Marketing GSK, restructure

GlaxoSmithKline has unveiled new appointments to its board of directors and the departure of its current president of Pharmaceuticals David …

Pharma calls for European ‘patient information partnerships’

December 10, 2007
Medical Communications

Pharmaceutical industry leaders are hoping that 2008 will see a breakthrough on one of the most contentious issues in European …

Avandia suffering less in Europe

December 10, 2007
Sales and Marketing Avandia, diabetes

New research by market data company TNS Healthcare suggests that fewer patients are being taken off Avandia in Europe than …

The Gateway to Local Adoption Series

Latest content